List/Grid

Tag Archives: Virus

HIV-positive women respond well to HPV vaccine, study shows

HIV-positive women respond well to HPV vaccine, study shows

HIV-positive women respond well to a vaccine against the human papillomavirus (HPV), even when their immune system is struggling, according to newly published results of an international clinical trial. Continue reading

New combination drug therapy proves very effective in hepatitis C treatments

New combination drug therapy proves very effective in hepatitis C treatments

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy Continue reading

New combination drug therapy proves very effective in hepatitis C treatments

New combination drug therapy proves very effective in hepatitis C treatments

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show promise for a new option that could help lead to both an increase in patients cured with a much more simple and tolerable all oral therapy Continue reading

New Chinese herbal medicine has significant potential in treating hepatitis C, study suggests

New Chinese herbal medicine has significant potential in treating hepatitis C, study suggests

ata from a late-breaking abstract presented at the International Liver CongressTM 2014 identifies a new compound, SBEL1, that has the ability to inhibit hepatitis C virus (HCV) activity in cells at several points in the virus’ lifecycle.i SBEL1 is a compound isolated from Chinese herbal medicines that was found to inhibit HCV activity by approximately 90%. SBEL1 is extracted from a herb found in certain regions of Taiwan and Southern China. Continue reading

Viral hepatitis more deadly than HIV in Europe

Viral hepatitis more deadly than HIV in Europe

Mortality from viral hepatitis is significantly higher than from HIV/AIDS across EU countries, according to results from The Global Burden of Disease Study 2010 (GBD 2010) which was announced for the first time today at the International Liver CongressTM 2014. Continue reading

Guinea ‘Ebola deaths pass 100′

Guinea ‘Ebola deaths pass 100′

unable to retrieve full-text contentThe Ebola outbreak could take up to four months to contain as the number of people killed by the virus in Guinea passes 100, the UN says. Continue reading

Rilpivirine combination product in pretreated HIV-1 patients: Added benefit not proven

Rilpivirine combination product in pretreated HIV-1 patients: Added benefit not proven

The German Institute for Quality and Efficiency in Health Care (IQWiG) reassessed the antiviral drug combination rilpivirine/emtricitabine/tenofovir. Continue reading

Rilpivirine combination product in pretreated HIV-1 patients: Added benefit not proven

Rilpivirine combination product in pretreated HIV-1 patients: Added benefit not proven

The German Institute for Quality and Efficiency in Health Care (IQWiG) reassessed the antiviral drug combination rilpivirine/emtricitabine/tenofovir. In early 2012, the combination was approved for the treatment of adults infected with human immunodeficiency virus type 1 (HIV-1) who have not received previous antiretroviral treatment. Continue reading

From mouse ears to human’s? Gene therapy to address progressive hearing loss

From mouse ears to human’s? Gene therapy to address progressive hearing loss

One in a thousand children in the United States is deaf, and one in three adults will experience significant hearing loss after the age of 65. Continue reading

Drugs fail to reawaken dormant HIV infection

Drugs fail to reawaken dormant HIV infection

Scientists at Johns Hopkins report that compounds they hoped would “wake up” dormant reservoirs of HIV inside immune system T cells — a strategy designed to reverse latency and make the cells vulnerable to destruction — have failed to do so in laboratory tests of such white blood cells taken directly from patients infected with HIV. “Despite our high hopes, none of the compounds we tested in HIV-infected cells taken directly from patients activated the latent virus,” says Robert F. Continue reading